Page last updated: 2024-11-02

pirenzepine and Multiple System Atrophy Syndrome

pirenzepine has been researched along with Multiple System Atrophy Syndrome in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research Excerpts

ExcerptRelevanceReference
" In the case presented, the good efficacy of olanzapine in low dosage over an extended period of time is described."1.31[Delusional ectoparasitic infestation in multiple system atrophy]. ( Kornhuber, M; Kumbier, E, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumbier, E1
Kornhuber, M1

Other Studies

1 other study available for pirenzepine and Multiple System Atrophy Syndrome

ArticleYear
[Delusional ectoparasitic infestation in multiple system atrophy].
    Der Nervenarzt, 2002, Volume: 73, Issue:4

    Topics: Basal Ganglia; Benzodiazepines; Delusions; Diagnosis, Differential; Ectoparasitic Infestations; Fema

2002